Analyst firms · H.C. Wainwright · ETON
H.C. Wainwright ETON price target and rating history
Eton Pharmaceuticals Inc. (ETON) · Health Care
H.C. Wainwright rates Eton Pharmaceuticals Inc. (ETON) Buy with a $33 price target, as of its latest action on Jan 23, 2025. It has published 3 rating actions on ETON since September 2024, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $33
- Median target, all firms
- Too few
- Actions on ETON
- 3
H.C. Wainwright price target on ETON
Every H.C. Wainwright rating on ETON
- Jan 23, 2025
- Jan 6, 2025
- Sep 4, 2024
Questions about H.C. Wainwright and ETON
- What is H.C. Wainwright's price target for ETON?
- H.C. Wainwright's latest stated price target for Eton Pharmaceuticals Inc. (ETON) is $33, from its action on Jan 23, 2025.
- What is H.C. Wainwright's rating on ETON?
- H.C. Wainwright rates ETON Buy, a bullish rating, as of Jan 23, 2025.
- When did H.C. Wainwright last change its view on ETON?
- On Jan 23, 2025, H.C. Wainwright raises its price target to $33 from $17, keeps Buy.
All H.C. Wainwright ratingsETON news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.